Teva Pharmaceutical Industries Limited Ordinary Shares (NY:TEVA)

39.98 +0.45 (+1.15%)

Delayed Quote Updated: 12:45 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited Ordinary Shares

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

35 36 Next >

Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape ↗

June 12, 2023

The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply since March. Methotrexate is an injected medication utilized to treat...

Via Benzinga

Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

June 12, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

June 12, 2023

From Alvotech

Via GlobeNewswire

Why Teva Pharmaceutical Stock Is Jumping Today ↗

May 18, 2023

Investors are reacting positively to Teva's new growth strategy.

Via The Motley Fool

Teva Pharma Crumbles After First-Quarter Earnings Miss, Flat Sales ↗

May 10, 2023

Teva reported absolutely flat sales in the first quarter and light earnings.

Via Investor's Business Daily

Teva Pharmaceutical Clocks Lower Profits On Flat Q1 Sales, Sticks To Annual Guidance ↗

May 10, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 09, 2023

Via Benzinga

Is AbbVie or Amgen the Better Bargain Buy Right Now? ↗

June 08, 2023

These elite drugmakers are both working through a number of headwinds.

Via The Motley Fool

Teva Concludes Nationwide Opioids Settlement Agreement

June 08, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management

June 06, 2023

From Phil Inc.

Via Business Wire

Teva Pharmaceutical Indus: Q1 Earnings Insights ↗

May 10, 2023

Via Benzinga

Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy? ↗

June 05, 2023

It's unclear whether the pivot will be enough to halt its recent decline.

Via The Motley Fool

Teva Presents Real-World Data for AUSTEDO® (deutetrabenazine) Tablets with 4-Week Patient Titration Kit at Psych Congress Elevate 2023

June 02, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 25, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023 ↗

May 25, 2023

Via Benzinga

Teva to Present Data Demonstrating UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolonged Time to Impending Relapse for Adults with Schizophrenia at the American Psychiatric Association’s 2023 Annual Meeting

May 20, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023 ↗

May 18, 2023

Via Benzinga

Why Is Alimera Sciences (ALIM) Stock Up 21% Today? ↗

May 18, 2023

Alimera Sciences (ALIM) stock is taking off on Thursday after signing a major deal with EyePoint Pharmaceuticals (EYPT).

Via InvestorPlace

Why Is Teva Pharmaceuticals (TEVA) Stock Up Today? ↗

May 18, 2023

Teva Pharmaceuticals (TEVA) stock is climbing higher on Thursday after the pharmaceutical company announced a new growth strategy.

Via InvestorPlace

Netflix, Synopsys, Madison Square Garden Entertainment And Other Big Stocks Moving Higher On Thursday ↗

May 18, 2023

U.S. stocks traded mixed, with the Dow Jones dropping around 50 points on Thursday. Here are some big stocks recording gains in today’s session. Urstadt Biddle Properties Inc. (NYSE: UBP) shares surged...

Via Benzinga

Teva Launches New “Pivot to Growth” Strategy

May 18, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories ↗

May 17, 2023

Benzinga

Via Benzinga

One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps ↗

May 17, 2023

AstraZeneca Plc (NASDAQ: AZN) has decided to leave a U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), making it the third company to leave the group in the last...

Via Benzinga

A Bitter Pill to Swallow: Teva's $235M Challenge to GSK Dismissed by Supreme Court ↗

May 15, 2023

The U.S.

Via Benzinga

AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, New Once-Daily Formulation of AUSTEDO®, Now Available in the U.S.

May 15, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 12, 2023

Via Benzinga

Teva Pharmaceutical Industries (TEVA) Q1 2023 Earnings Call Transcript ↗

May 10, 2023

TEVA earnings call for the period ending March 31, 2023.

Via The Motley Fool

Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook

May 10, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Nasdaq, S&P 500 Futures Slip Ahead Of Inflation Data — But Analyst Hints It Still Might Be Ok To Be Bullish ↗

May 10, 2023

Via Benzinga

Disney, Occidental Petroleum And 3 Stocks To Watch Heading Into Wednesday ↗

May 10, 2023

With US stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.